The global Early Toxicity Testing Market was pegged at $614 million in 2015 and is projected to reach $1,012 million by 2022, registering a CAGR of 7.3% during the period 2016–2022.
Rise in adoption of early toxicity to reduce drug failure in later stages, frequent replacement of in vivo models by in vitro model, and increase in stringent policies of regulatory authorities concerning public health welfare have boosted the growth of the early toxicity testing market. However, limited awareness regarding the benefits of early toxicity testing and limitation of preclinical testing hamper market growth. On the contrary, rapid advancements in in silico platforms and in vitro models are expected to create lucrative opportunities in the near future.
Download Sample Report: https://www.alliedmarketresearch.com/request-sample/619
The report splits into technique, end users, and geography. On the basis of technique, the report divides into in vivo, in vitro, and in silico. Moreover, the in vitro technique is further segmented into enzyme toxicity assays, bacterial toxicity assays, cell-based ELISA and western blots, tissues culture assays, receptor binding assays, and other assays. The in vivo segment dominated the market in 2015 and is expected to continue its dominance throughout the study period.
Based on end users, the report bifurcates into the pharmaceuticals industry, diagnostics industry, food industry, chemicals industry, cosmetics industry, and other industries. The pharmaceutical industry is expected to manifest the fastest CAGR by 2022 and projected to hold the largest share in 2022, contributing about two-thirds of the total market. This is attributed to rise in number of clinical trials for drug development. However, the cosmetic industry is projected to portray a CAGR of 9.8% during the study period.
The report is segmented according to region into Asia-Pacific, North America, Europe, and LAMEA. Europe held the largest market share and is expected to manifest CAGR of 6.6% through 2022. However, China is the fastest growing country in the Asia-Pacific region, with a CAGR of 15.8% during the forecast period.
The report analyzes the leading market players including Thermo Fisher Scientific Inc., Agilent Technologies Inc., Merck & Co., Inc., Becton, Danaher Corporation, The Jackson Laboratory, Bio-Rad Laboratories, Inc., Quest Diagnostics Incorporation, Charles River Laboratories International Incorporation, Dickinson And Company, and Evotec Ag.
For More Information: https://www.alliedmarketresearch.com/purchase-enquiry/619
About us
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.
Contact
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Your information will never be shared with any third party.